Chalmers Jenny, Ritter Alison, Berends Lynda
National Drug and Alcohol Research Centre, UNSW Australia, Australia.
Drug Policy Modelling Program, National Drug and Alcohol Research Centre, UNSW Australia, Australia.
Addiction. 2016 Nov;111(11):2041-2049. doi: 10.1111/add.13473. Epub 2016 Jul 21.
To estimate the amount of alcohol and other drug (AOD) treatment provided and number of treatment recipients in Australia in 2011-12, and document an approach for future estimates internationally.
We combined multiple data sources to estimate the amount of treatment received: administrative data on AOD treatment funded by the Australian and state/territory governments, survey data from treatment providers and programme evaluation data. The various data sources were reconciled, using published studies of treatment activity, to estimate the unique number of treatment recipients.
Treatment funded by the Australian and state/territory governments provided by general practitioners, specialist treatment services, hospitals, community- and hospital-based ambulatory mental health-care services and allied health professionals.
People receiving AOD treatment in the above settings.
Annual quantum of AOD treatment (encounters, episodes, consultations) and the number of unique treatment recipients.
In 2011/12 we estimated 1.6 million episodes of care, consultations or encounters, noting that measures of treatment are not comparable. Based on a range of conversion rates to account for people accessing treatment multiple times in that year, we estimated that the number of Australians in receipt of AOD treatment ranged from 202 168 to 232 419. This is an underestimate and subject to error. Using the upper range of the estimate, on average each treatment recipient made 4.7 visits to a general practitioner (GP) or allied health professional providing mental health services for AOD treatment, and had 1.2 treatment episodes with a specialist AOD treatment provider and/or hospital.
Between 202 168 and 232 419 Australians are estimated to have received alcohol and other drug treatment in 2011-12. The comprehensive approach used to calculate this estimate, combining multiple independent data sets across treatment settings and programmes, can be replicated in other countries.
估算2011 - 12年澳大利亚提供的酒精及其他药物（AOD）治疗量以及治疗接受者数量，并记录一种未来在国际上进行估算的方法。
我们整合了多个数据源来估算接受治疗的量：澳大利亚及州/领地政府资助的AOD治疗行政数据、治疗提供者的调查数据以及项目评估数据。利用已发表的治疗活动研究对各种数据源进行核对，以估算治疗接受者的独特数量。
由澳大利亚及州/领地政府资助的治疗，由全科医生、专科治疗服务机构、医院、社区及医院门诊心理健康护理服务机构以及相关健康专业人员提供。
在上述背景下接受AOD治疗的人群。
AOD治疗的年度量（诊疗次数、疗程、会诊次数）以及独特治疗接受者的数量。
在2011/12年，我们估算有160万次护理、会诊或诊疗，注意治疗量的测量方法不具有可比性。基于一系列转化率来考虑当年多次接受治疗的人群，我们估算接受AOD治疗的澳大利亚人数在202168至232419人之间。这是一个低估且存在误差。采用估算范围的上限，平均每位治疗接受者会去全科医生（GP）或提供AOD治疗心理健康服务的相关健康专业人员处就诊4.7次，并与专科AOD治疗提供者和/或医院有1.2个治疗疗程。
据估算，在2011 - 12年期间，有202168至232419名澳大利亚人接受了酒精及其他药物治疗。用于计算此估算值的综合方法，即将治疗背景和项目中的多个独立数据集相结合，可在其他国家复制。
